1. 807PProlonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study. (23rd October 2018) Authors: Tombal, B; Hussain, M; Penson, D; Attard, G; Sternberg, C N; Phung, D; Morlock, R; Modelska, K; Ramaswamy, K; Ivanescu, C; Saad, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗